Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DX01 vs metronidazole suppository in trichomonal vaginitis and bacterial vaginosis
CTR20140597Phase 3Active
- Sponsor
- Hanli Biomedical
- Start
- Sep 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dequalinium in trichomonal vaginitis, bacterial vaginosis (BV), sponsored by Hanli Biomedical. Started Sep 2014; status: active.
02
Drugs
dequalinium
03
Conditions
trichomonal vaginitisbacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20140597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140597.